Strata Critical Medical (SRTA) Treasury Shares (2021 - 2026)

Strata Critical Medical has disclosed Treasury Shares across 6 years of filings, most recently posting $13.6 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 24.61% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $13.6 million (up 24.61% YoY), while the FY2025 annual figure was $9.7 million, up 4.95% from the prior year.
• Treasury Shares rose to $13.6 million in Q1 2026, from $9.7 million in the prior quarter.
• Over the last five years, Treasury Shares for SRTA reached as high as $13.6 million in Q1 2026 and fell as low as $2.4 million in Q3 2022.
• The 5-year median for Treasury Shares is $9.3 million (2024), against an average of $8.1 million.
• Annual changes were most pronounced in 2022 — Treasury Shares soared 243.54% — and 2023, when it slipped 29.55%.
• A 5-year view of Treasury Shares shows it stood at $7.5 million in 2022, then retreated by 29.55% to $5.3 million in 2023, then jumped by 76.54% to $9.3 million in 2024, then rose by 4.95% to $9.7 million in 2025, then soared by 39.11% to $13.6 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $13.6 million, $9.7 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.